SmartDose® 3.5 Injector

Leading the way with integrated containment and delivery solutions

The first combination product that incorporates the SmartDose® 3.5 Injector has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose injector offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.

SmartDose 3.5 Logo



Proud to support our partners with our SmartDose® technology: 

Amgen Logo RocheSC Pharma

Since 2010, West has invested in development of our SmartDose® technology scaling it to meet various application and delivery volume needs.

  • User loaded, subcutaneous self-administration
  • Ability to deliver high volume and high viscosity drug products 
  • Easy to use, intuitive design 
  • Visual, tactile and audible feedback to boost user confidence 
  • Training solutions available for a seamless onboarding experience
  • Address a variety of delivery times through adaptable, pre-programmable technology 
  • Multiple published studies* indicate lower pain with customizable delivery rates
  • Regulatory, Quality and Human Factors expertise to support your development

*Dias, C., Abosaleem, B., Crispino, C., Gao, B. & Shaywitz, A. (2015). Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects. AAPS PharmSciTech. DOI: 10.1208/s12249-015-0288-y

SmartDose 3.5 Platform Technical Specs

SmartDose 3.5 Logo









SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc.

Flurotec® is a registered trademark of Daikyo Seiko, Ltd.”  

SelfDose™ is a trademark of West Pharmaceutical Services, Inc. 

The logos above are the property of their respective owners and are used with permission.